Confronting CJD and other Prion Diseases: Science, Sense, Support
Contributors:
- Peter T. Ostrow, MD, PhD
Associate Professor of Pathology and Neurology
State University of New York at Buffalo
School of Medicine and Biomedical Sciences
The Jacobs Neurological Institute
Buffalo, NY
- Pierluigi Gambetti, MD
Professor and Director, Division of Neuropathology,
Case Western Reserve University
School of Medicine and University Hospitals of Cleveland
Director National Prion Disease Pathology Surveillance Center
Medical Director, Creutzfeldt Jakob Disease Foundation
- Richard Johnson, MD
Distinguished Service Professor of Neurology
Johns Hopkins University School of Medicine
- Richard Knight, MD
Director, National CJD Surveillance Unit, Edinburgh Scotland
- Robert Will, MD
Professor of Clinical Neurology, University of Edinburgh
Founding Director, National CJD Surveillance Unit, Edinburgh Scotland
- H. Branch Coslett, MD
Professor of Neurology
Chief, Section of Cognitive Neurology,
University of Pennsylvania
Producers
Kathy Nelson, Peter Ostrow, MD, PhD
Educational Consultant
Kevin Crosby, PhD
Full Circle Studios
Animations and Graphics
Todd Fiore, B.F.A.
Videography Editing
Michael Mombrea, Jr., Jeff Philips, Jerry MacKay
Editing
Jerry MacKay
Faculty Disclosure Statement
Presentations represent the work and opinions of the contributors and do not
necessarily represent the views of the University at Buffalo School of Medicine
and Biomedical Sciences. This presentation may contain references to unlabeled,
unapproved uses of products. Participants should consult full prescribing
information before prescribing any drug discussed in this program.
Contributors have been asked to disclose any relationship(s) they may have
with any commercial supporter of this CME activity or with companies providing
drugs, medical equipment, etc., which may have relevance to the content of
their presentations or discussion. This disclosure is intended to provide
participants with sufficient information to evaluate whether any given presentation
has been influenced by the faculty's relationship(s) or financial interests
with said companies.
- Peter Ostrow, MD, PhD Honoraria: none; Support for Educational Productions:
Biogen Idec, Sanofi-Synthelabo, Pfizer; Consultancies: Medtronic; Stock ownership:
none.
- Pierluigi Gambetti, MD
Honoraria: Ferring Corporation, Pall Corporation; Consultancies: Ferring Corporation;
Stock ownership: None; Research Support: Ferring Corporation.
- Richard Johnson, MD
Honoraria: none; Consultancies: none; Stock ownership: Cephalon; Research
Support: none.
- Richard Knight, MD
Honoraria: none; Consultancies: none; Stock ownership: None; Research Support:
none.
- Robert Will, MD
Honoraria: none; Consultancies: none; Stock ownership: None; Research Support:
none.
- H. Branch Coslett, MD
Honoraria: Pfizer; Consultancies: none; Stock ownership: None; Research Support:
none.